| 151 | 32053938 | Risk Assessment of Cosmetics Using Triclosan on Future Generation's Germ Cell Maturation via Lactating Mother Rats. | Int J Environ Res Public Health | 2020 Feb 11 |
1 |
| 152 | 32101757 | Atorvastatin attenuates obese-induced kidney injury and impaired renal organic anion transporter 3 function through inhibition of oxidative stress and inflammation. | Biochim Biophys Acta Mol Basis Dis | 2020 Jun 1 |
1 |
| 153 | 32104494 | Piperacillin enhances the inhibitory effect of tazobactam on β-lactamase through inhibition of organic anion transporter 1/3 in rats. | Asian J Pharm Sci | 2019 Nov |
4 |
| 154 | 32159797 | Potent Inhibitors of Organic Anion Transporters 1 and 3 From Natural Compounds and Their Protective Effect on Aristolochic Acid Nephropathy. | Toxicol Sci | 2020 Jun 1 |
1 |
| 155 | 32197469 | A Novel Alternative in the Treatment of Detrusor Overactivity? In Vivo Activity of O-1602, the Newly Synthesized Agonist of GPR55 and GPR18 Cannabinoid Receptors. | Molecules | 2020 Mar 18 |
3 |
| 156 | 32311818 | Serotonin homeostasis in the materno-foetal interface at term: Role of transporters (SERT/SLC6A4 and OCT3/SLC22A3) and monoamine oxidase A (MAO-A) in uptake and degradation of serotonin by human and rat term placenta. | Acta Physiol (Oxf) | 2020 Aug |
1 |
| 157 | 32373203 | Organic anion transporters also mediate the drug-drug interaction between imipenem and cilastatin. | Asian J Pharm Sci | 2020 Mar |
6 |
| 158 | 32606592 | Treatment with a PPAR-γ Agonist Protects Against Hyperuricemic Nephropathy in a Rat Model. | Drug Des Devel Ther | 2020 |
1 |
| 159 | 32630784 | Nano Ellagic Acid Counteracts Cisplatin-Induced Upregulation in OAT1 and OAT3: A Possible Nephroprotection Mechanism. | Molecules | 2020 Jul 2 |
6 |
| 160 | 32671657 | Evaluation of possible pharmacokinetic interaction between methotrexate and proton pump inhibitors in rats. | Pharmacol Rep | 2020 Oct |
13 |
| 161 | 32733244 | O-1602, an Agonist of Atypical Cannabinoid Receptors GPR55, Reverses the Symptoms of Depression and Detrusor Overactivity in Rats Subjected to Corticosterone Treatment. | Front Pharmacol | 2020 |
1 |
| 162 | 33132311 | Inflammation-Induced Attenuation of Prostaglandin D<sub>2</sub> Elimination across Rat Blood-Brain Barrier: Involvement of the Downregulation of Organic Anion Transporter 3 and Multidrug Resistance-Associated Protein 4. | Biol Pharm Bull | 2020 |
4 |
| 163 | 33137430 | Effects of rhein and Rheum palmatum L. extract on the pharmacokinetics and tissue distribution of aristolochic acid I and its demethylated metabolite in rats. | J Ethnopharmacol | 2021 Mar 1 |
1 |
| 164 | 33623845 | (-)-Epigallocatechin-3-gallate Inhibits Human and Rat Renal Organic Anion Transporters. | ACS Omega | 2021 Feb 16 |
3 |
| 165 | 33709304 | Peptide Hormone Insulin Regulates Function, Expression, and SUMOylation of Organic Anion Transporter 3. | AAPS J | 2021 Mar 11 |
3 |
| 166 | 33753216 | Role of organic anion transporter 3 in the renal excretion of biapenem and potential drug-drug interactions. | Eur J Pharm Sci | 2021 Jul 1 |
4 |
| 167 | 33858651 | CP-25 ameliorates methotrexate induced nephrotoxicity via improving renal apoptosis and methotrexate excretion. | J Pharmacol Sci | 2021 May |
2 |
| 168 | 34081941 | Agomelatine protects against obesity-induced renal injury by inhibiting endoplasmic reticulum stress/apoptosis pathway in rats. | Toxicol Appl Pharmacol | 2021 Aug 15 |
1 |
| 169 | 34452094 | Effects of 1α,25-Dihydroxyvitamin D<sub>3</sub> on the Pharmacokinetics of Procainamide and Its Metabolite N-Acetylprocainamide, Organic Cation Transporter Substrates, in Rats with PBPK Modeling Approach. | Pharmaceutics | 2021 Jul 25 |
1 |
| 170 | 35104569 | Freshly isolated retinal capillaries to determine efflux transporter function at the inner BRB. | J Control Release | 2022 Mar |
6 |
| 171 | 35112329 | Acyclovir Brain Disposition: Interactions with P-gp, Bcrp, Mrp2, and Oat3 at the Blood-Brain Barrier. | Eur J Drug Metab Pharmacokinet | 2022 Mar |
5 |
| 172 | 35114312 | Adefovir accumulation in the renal interstitium triggers mast cell degranulation and promotes renal interstitial fibrosis. | Toxicol Lett | 2022 Apr 15 |
2 |
| 173 | 35490314 | Interactions between meropenem and renal drug transporters. | Curr Drug Metab | 2022 Apr 28 |
6 |